Benjamin F. Edwards & Company, Inc. Moderna, Inc. Transaction History

Benjamin F. Edwards & Company, Inc.

$5.69 Billion
Q2 2024

A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 5,343 shares of MRNA stock, worth $150,352. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,343

Previous 1,345 297.25%

Holding current value

$150,352

Previous $144,000 340.28%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $404,637 - $666,106	3,998 Added 297.25%	5,343 $634,000
Q1 2024 Apr 29, 2024	SELL	$85.37 - $115.44 $35,513 - $48,023	-416 Reduced 23.62%	1,345 $144,000
Q4 2023 Feb 06, 2024	BUY	$69.51 - $104.43 $17,933 - $26,942	258 Added 17.17%	1,761 $175,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $8,580 - $11,268	89 Added 6.29%	1,503 $155,000
Q2 2023 Aug 15, 2023	BUY	$118.5 - $160.53 $10,309 - $13,966	87 Added 6.56%	1,414 $172,000
Q1 2023 Apr 27, 2023	SELL	$135.66 - $197.02 $131,318 - $190,715	-968 Reduced 42.18%	1,327 $204,000
Q4 2022 Feb 07, 2023	BUY	$118.38 - $210.04 $117,432 - $208,359	992 Added 76.13%	2,295 $412,000
Q3 2022 Oct 28, 2022	BUY	$118.07 - $194.18 $115,472 - $189,908	978 Added 300.92%	1,303 $154,000
Q1 2022 May 04, 2022	BUY	$126.46 - $235.05 $21,245 - $39,488	168 Added 107.01%	325 $56,000
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $1.48 Million - $2.41 Million	-6,541 Reduced 97.66%	157 $40,000
Q3 2021 Nov 02, 2021	BUY	$221.9 - $484.47 $1.08 Million - $2.35 Million	4,853 Added 263.04%	6,698 $2.58 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $114,840 - $207,722	884 Added 91.99%	1,845 $434,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $71,512 - $121,816	-655 Reduced 40.53%	961 $126,000
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $93,087 - $240,521	1,416 Added 708.0%	1,616 $169,000
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $5,434 - $9,485	100 Added 100.0%	200 $14,000
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $7,120 - $19,200	-240 Reduced 70.59%	100 $6,000
Q1 2020 May 07, 2020	BUY	$17.78 - $31.58 $6,045 - $10,737	340 New	340 $10,000
Q4 2019 Feb 06, 2020	SELL	$13.93 - $21.28 $8,358 - $12,768	-600 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$13.7 - $28.34 $4,110 - $8,502	300 Added 100.0%	600 $9,000
Q4 2018 Jan 31, 2019	BUY	$13.52 - $18.8 $4,056 - $5,640	300 New	300 $5,000

Others Institutions Holding MRNA

# of Institutions

874

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $11B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.

Account

Benjamin F. Edwards & Company, Inc. Moderna, Inc. Transaction History